Amanda Dilda

Amanda Dilda

Auto-generated profile, based on publicly available information

Amanda Dilda

Universidade do Estado de Santa Catarina

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
AAAmanda B. Almeida
Amanda B. Almeida
DADenise Nunes Araujo
Denise Nunes Araujo
JSJoão V. Strapazzon
João V. Strapazzon
CRCleiciane Rita
Cleiciane Rita
ADAmanda Dilda
Amanda Dilda
ASALEKSANDRO S.Da Silva
ALEKSANDRO S.Da Silva
The objective of this study was to evaluate whether the addition of a blend based on α-monolaurin mono-, di- and triglycerides of butyric acid, and lysolecithin on the performance even on diets containing reduced inclusion of oil in the diet and without the use of growth-promoting antibiotics of broilers considering the effect on health, performance, and meat. Three treatments were defined: positive control (TP: with enramycin), negative control (TN: no enramycin), and blend (T-FRA: with monolaurin and glycerides of acid butyric minus 0.8% soybean oil). At 21 days, broilers treated with TP and T-FRA obtained the lower feed conversion ratio (FC); at 35 days, T-FRA broilers obtained lower FC than TN broilers. Cholesterol levels were higher in the blood of T-FRA broilers. On day 42, levels of ROS and TBARS were lower in the intestine, muscles, and liver of T-FRA broilers. Moreover, glutathione S-transferase and total non-enzymatic antioxidants were greater at the intestinal and muscular levels. The T-FRA broilers had a lower percentage of lipids in the meat. The MIC indicated that 111mg of the blend/mL inhibited the growth of E. coli; however, the counts of total coliforms and E. coli in the feces and the broilers' litter did not differ between treatments. In conclusion, the addition of the blend T-FRA in broiler diets was able to improve the feed conversion and maintain the other performance parameters even considering a reduction of 0.8% in the inclusion of oil.

1 February 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
Guilherme Luiz DeolindoGuilherme Luiz Deolindo
Guilherme Luiz Deolindo
VMVitor Luiz Molosse
Vitor Luiz Molosse
ADAmanda Dilda
Amanda Dilda
LGLilian Kolling Girardini
Lilian Kolling Girardini
Marcelo VedovattoMarcelo Vedovatto
Marcelo Vedovatto
DADenise Nunes Araujo
Denise Nunes Araujo
The aim of this study was to evaluate the antimicrobial potential of the aqueous extract of green propolis in vitro against mastitis-causing and in vivo bacteria, evaluating the efficacy of treatment in Lacaune sheep. In the in vitro test, the minimum inhibitory concentration (MIC) was used; first, the MIC was obtained from the aqueous extract of green propolis for the strain of Staphylococcus. aureus ATCC 25523, defined as 1 mg/ml. For bacterial agents isolated from sheep with mastitis (Staphylococcus epidermidis, Staphylococcus intermedius, Staphylococcus hyicus, Corynebacterium spp. and Acinetobacter spp.), The concentration of 10 mg/ml was determined, while for Streptococcus equinus, Escherichia coli, and hemolytic E. coli, also isolated from sheep with mastitis, the concentration capable of reducing bacterial growth was 100 mg/ml. In the in vivo test, ten sheep were used, distributed in two treatments, five in the control group (CG) that received 2.5 ml of saline (vehicle), and five in the treated group (GT) that received 2.5 ml of aqueous (saline) propolis extract by the mammary route. The propolis dose tested (0.1 g/ml) was not effective for the treatment of mastitis, because the sheep remained positive in the racket test (CMT). The main microorganism isolated in the cases of mastitis in this study was Staphylococcus epidermidis. These results are preliminary; however, at the tested dose, the aqueous extract of green propolis delivered by the mammary route had no curative effect of mastitis.